Groff Health Applies for Large-Scale Drug Manufacturing
Published Date: 1/21/2025
Notice
Summary
Groff Health, Inc. wants to become a big-time maker of certain controlled drugs. This means they’ll be officially allowed to produce these substances in large amounts. If approved, it could affect companies and people who rely on these drugs, with no immediate cost changes announced.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Groff Health Seeks Bulk Manufacturer Registration
Groff Health, Inc. has applied to be registered as a bulk manufacturer of certain controlled substances so it would be officially allowed to produce those drugs in large amounts. The notice says this application could affect companies and people who rely on these drugs, and it notes there are no immediate cost changes announced.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in